Skip to content

Comunicados de prensa

Stratus Medical raises $10 million Series B to complete development of new technology and fund clinical trial

por

MAGNOLIA, Texas, Feb. 4, 2026 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced a $10 million Series B financing. The financing was led by Wasatch Health Partners, a healthcare-focused investment firm pursuing growth equity and lower middle-market buyout strategies. Wasatch Health Partners invested through its Growth Fund and previously provided a $25 million convertible debt facility through its Structured Capital platform.

Stratus® Medical anuncia acuerdo de distribución exclusiva con AMS Group SRL para Italia

por

Stratus Medical announces exclusive distribution agreement with AMS GROUP SRL to bring the NIMBUS® RF Multitined Expandable Electrode to Italy! 🇮🇹 AMS GROUP SRL is a leading medical device distributor focused on interventional pain therapies. AMS will launch NIMBUS in Italy with an upcoming educational education program. Will Pankey, VP of Sales for Stratus, is … Leer más

Stratus® Medical anuncia un acuerdo de distribución exclusiva con Edge Medical para el Reino Unido

por

Stratus® Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom MAGNOLIA, Texas, Aug. 22, 2024 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for pain, is pleased to announce an exclusive distribution agreement with Edge Medical, a leading medical device distributor serving the United Kingdom. Edge Medical will distribute the innovative … Leer más

Stratus® Medical anuncia la continua expansión de su cobertura de propiedad intelectual en Europa con adiciones a su cartera global de patentes para el Electrodo Expandible Multidireccional RF Electroquirúrgico NIMBUS® y el registro de un diseño comunitario para una nueva tecnología de plataforma en desarrollo.

por

MAGNOLIA, Texas, April 29, 2024 /PRNewswire/ — Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency (RF) technology for the treatment of pain, announced today the expansion of patent protection in Europe for its NIMBUS® Electrosurgical RF Multitined Expandable Electrode (“NIMBUS”) with the issuance of European Patent Numbers EP3556308 and EP3750501. Both … Leer más

Nuevas pruebas retrospectivas de la ARF con NIMBUS, para el dolor de la articulación sacroilíaca, comparando dos técnicas en 182 pacientes a los 12 meses

por

Nuevas pruebas retrospectivas de la ablación por radiofrecuencia con Nimbus, para el dolor de la articulación sacroilíaca, comparando dos técnicas en 182 pacientes a los 12 meses. Enhorabuena a los autores por la publicación de este manuscrito que está disponible en línea en acceso abierto: https://esmed.org/MRA/mra/article/view/4978 Citation: Wright RE and Block JE, 2023. Radiofrequency Neurotomy for Sacroiliac Joint Pain: Twelve Month Outcomes and Comparison Between Two … Leer más

Stratus® Medical anuncia la inscripción del primer paciente en un importante ensayo comparativo, aleatorizado y doble ciego que compara el dispositivo de ablación por radiofrecuencia Nimbus® con la ablación por radiofrecuencia convencional para el tratamiento del dolor de la articulación sacroilíaca.

por

MAGNOLIA, Texas, March 2, 2023 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for pain, and the University of Utah, Department of Physical Medicine and Rehabilitation, announced today the first patient enrolled in the COBRA study, a double-blinded, randomized trial, comparing the bipolar treatment with Nimbus® RF Multitined Expandable Electrode to conventional radiofrequency … Leer más

Stratus® Medical anuncia la concesión de la tercera patente en Estados Unidos para el electrodo expandible Nimbus® RF Multitined utilizado en el tratamiento del dolor

por

MAGNOLIA, Texas, Feb. 23, 2021 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office has granted a third U.S. patent related to its Nimbus® RF Multitined Expandable Electrode. U.S. Patent No. 10,925,664, titled METHODS FOR RADIO FREQUENCY NEUROTOMY, issued on February … Leer más

Stratus® Medical anuncia la concesión de dos nuevas patentes en Estados Unidos para el electrodo expandible Nimbus® RF Multitined utilizado en el tratamiento del dolor

por

SALT LAKE CITY, Sept. 14, 2020 /PRNewswire/ — Stratus®  Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office has granted two new patents related to its Nimbus® RF Multitined Expandable Electrode. U.S. Patent No. 10,716,618, titled System and Methods for Tissue Ablation, issued … Leer más

Stratus® Medical anuncia la autorización 510k de la FDA para la cánula de radiofrecuencia Vesta® para ampliar la cartera de productos y los primeros tratamientos de pacientes con Vesta en Estados Unidos

por

SALT LAKE CITY, July 27, 2020 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced today FDA clearance for the Vesta RF Cannula for use in radiofrequency (RF) heat lesion procedures for the relief of pain and first Vesta patient treatments in the United States.   Vesta was developed to provide our … Leer más